Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jun 19;16(3):2881–2886. doi: 10.3892/ol.2018.8990

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Presti et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 2. — Correlation between overall survival and expression levels (A) MIF, (B) D-DT, (C) CD74, (D) CD44, (E) CXCR2, (F) CXCR4 and (G) JAB1 was performed using linear regression analysis and Pearson's test on glioblastoma samples. (H) Differences in MIF expression levels were calculated in glioblastoma samples from drug-naïve patients and patients who underwent neoadjuvant therapy. Data were retrieved from the The Cancer Genome Atlas dataset through the cBioportal web-based utility (cbioportal.org). *P<0.05, as indicated. MIF, macrophage migration inhibitory factor; D-DT, D-dopachrome tautomerase; CD, cluster of differentiation; CXCR, C-X-C Motif Chemokine Receptor; JAB1, c-Jun activation domain-binding protein-1.